6076 PMR20new20logo 45

The Postoperative Pain Management Market is slated to reach US$ 45,861.8 Million at a CAGR of 5.1% between 2026. The present scenario is that of consumers driving as well as the accelerating pace of alteration in the healthcare vertical. This drives the digitally-enabled, seamlessly connected, and on-demand clinician-patient interactions. As such, patient-centric delivery transcending geographical barriers would be the epicenter going forward.

The number of patients undergoing surgical procedures has increased significantly in the last few years. A notable rise in people suffering from chronic diseases such as cancer is also being witnessed of late. Patients who have undergone surgery require the administration of postoperative pain management drugs within 24 hours of the surgical procedure to reduce moderate to severe postoperative pain.

This has led to a spur in demand for postoperative pain management drugs in the global market. Further, there is a steadily growing awareness regarding palliative care among patients suffering from terminal illness. This is boosting the adoption of analgesics as effective postoperative pain management drugs.

Want Insights To Postoperative Pain Management Market? Ask For Sample! https://www.persistencemarketresearch.co/samples/24259

Company Profiles

  • Teva Pharmaceutical Industries Ltd.
  • Egalet Corporation
  • GlaxoSmithKline Plc.
  • Novartis AG
  • Allergan plc
  • Mylan N.V.
  • Pfizer Inc.
  • Purdue Pharma L.P
  • Janssen Pharmaceuticals, Inc.
  • Endo International plc
  • Pacira Pharmaceuticals Inc.

Planning To Conclude Your Strategy On A Decisive Note In The Postoperative Pain Management Market? Glance Through The “Methodology” Implied! https://www.persistencemarketresearch.co/methodology/24259

A new report by Persistence Market Research traces the growth trajectory of the global postoperative pain management market for a period of eight years from 2018 to 2026. According to the revenue projections indicated in the report, the global market for postoperative pain management is likely to cross a whopping US$ 45 Bn in revenue by the end of 2026, up from an estimated valuation of around US$ 30 Bn in 2018.

This is reflective of a growth rate of 5.1% during the period 2018 – 2026. The report highlights the various market revenue push and pull factors as well as the trends impacting growth and performance of the global market for postoperative pain management during the aforesaid period of study.

Manufacturers of Postoperative Pain Management Drugs Focused on Developing Formulations with Abuse-deterrent Properties

The opioid epidemic in the U.S has put extensive regulatory pressure on manufacturers of postoperative pain management drugs to develop opioids with abuse-deterrent properties. Several notable pharmaceutical companies are incorporating abuse-deterrent technologies to manufacture pain management drugs with novel formulations that are safe for consumption by patients without harmful side effects.

One of the innovations in the manufacturing of analgesics is the introduction of non-opioid drugs with extended release of the medication to provide relief to patients from postoperative pain for a longer period of time. This is expected to result in significant revenue growth of the global postoperative pain management market in the coming years.

How About Knowing The Product/Technology Driving The Postoperative Pain Management Market Before Investing Therein? Click The “Purchase Now” Button Of Our Postoperative Pain Management Market Report! https://www.persistencemarketresearch.com/checkout/24259

Key Trends Witnessed in the Postoperative Pain Management Market

Manufacturers of postoperative pain management drugs are entering into strategic collaborations and partnerships with pharmaceutical companies for developing non-opioid analgesics. The main objectives of these collaborations are – to create an integrated approach towards pain management; to prevent the diversion of prescription opioid medications; and to prevent signs of opioid abuse and addiction.

Tags: Postoperative Pain Management Market Forecast, Postoperative Pain Management Market, Postoperative Pain Management Market Insight

See Campaign: https://www.persistencemarketresearch.com/
Contact Information:
Persistence Market Research Address – 305 Broadway, 7th FloorNew York City, NY 10007 United States U.S. Ph. – +1-646-568-7751 USA-Canada Toll-free – +1 800-961-0353 Sales – sales@persistencemarketresearch.com

Tags:
Reportedtimes, Menafn, Extended Distribution, iCN Internal Distribution, Research Newswire, English